AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment
doi: 10.1136/gutjnl-2013-304901 65 MazaratiA
It would normally be in a dose of 500mg- 3g
Sublingual forms dissolve under your tongue, potentially bypassing some digestive breakdown
Shukla D, Mandal PK, Ersland L, Gruner ER, Tripathi M, et al
In addition to platform design, analytical characterization has become increasingly important for translational development